Transcranial Magnetic Stimulation (TMS) is a non-invasive, FDA/NICE/Health Canada/TGA-cleared treatment that uses focused magnetic pulses to stimulate underactive regions of the brain linked to depression and other mental health conditions. Unlike electroconvulsive therapy (ECT), TMS requires no anaesthesia, no surgery, and causes no memory impairment.

In United States, there are 382 verified TMS clinics offering this treatment. A full course typically consists of 20-40 sessions, delivered 5 days a week over 6-8 weeks. Each session lasts approximately 20-40 minutes, and patients typically resume normal activities immediately afterward.

20-40 min

Per Session

50-60%

Response Rate

No Surgery

Non-invasive

2 Conditions Treated with TMS

TMS is primarily used for treatment-resistant depression but has expanding clinical applications. In United States, clinics offer TMS for:

Major Depressive Disorder (MDD)

Primary TMS indication; typically requires 2+ failed medication trials

Obsessive-Compulsive Disorder (OCD)

FDA/NICE-cleared; often used when CBT alone is insufficient

Anxiety & Depression

Increasingly prescribed off-label with strong clinical evidence

Post-Traumatic Stress Disorder (PTSD)

Active research area; deep TMS showing promising results

Smoking Cessation

FDA-cleared TMS target; reduces nicotine cravings

Migraines & Chronic Pain

Emerging TMS applications with growing evidence base

3 Insurance Coverage & Cost in United States

FDA-cleared for major depressive disorder (MDD), obsessive-compulsive disorder (OCD), and smoking cessation, with coverage expanding for anxiety and PTSD. Medicare, BlueCross BlueShield, Aetna, Cigna, and UnitedHealthcare typically cover TMS when pre-authorised and when standard medication and psychotherapy have not provided adequate relief.

Covered by Insurance

Most U.S. insurance plans cover TMS with prior authorisation. Most patients pay a $30-$75 copay per session.

Self-Pay / No Insurance

Without insurance, TMS costs approximately $300-$500 per session without insurance; insurance-covered courses typically have a copay of $30-$75 per session. Many clinics offer payment plans to make treatment more affordable.

Check Your Insurance Eligibility

4 TMS Technologies Available in United States

The three main TMS devices are FDA/NICE/Health Canada/TGA-cleared and available at clinics in United States. Each uses a different coil design and stimulation protocol:

NeuroStar

Standard rTMS (Repetitive Transcranial Magnetic Stimulation)

The most widely used TMS system. Targets the left dorsolateral prefrontal cortex (DLPFC) for depression. Standard protocol: 37.5 min sessions, 5x/week for 6 weeks.

BrainsWay Deep TMS

H-Coil Deep TMS System

Uses an H-shaped coil that penetrates deeper and broader brain regions. Cleared for depression and OCD. May be effective for patients who did not respond to standard rTMS.

MagVenture

Focal TMS with Theta Burst Stimulation (TBS)

Offers both standard and accelerated Theta Burst protocols. TBS can reduce session time to 3-6 minutes with comparable efficacy to standard 37.5-minute sessions.

Compare TMS devices in detail ->

Frequently Asked Questions About TMS in United States

What is TMS therapy and how does it work?

Transcranial Magnetic Stimulation (TMS) uses focused magnetic pulses to stimulate underactive areas of the brain associated with depression and other mental health conditions. During a TMS session, a small coil is placed against your scalp - no surgery, no sedation, and no systemic side effects. Each session lasts 20-40 minutes, and most patients can drive home afterward. A full course typically involves 5 sessions per week over 6-8 weeks (20-40 sessions total).

Is TMS covered by insurance in United States?

FDA-cleared for major depressive disorder (MDD), obsessive-compulsive disorder (OCD), and smoking cessation, with coverage expanding for anxiety and PTSD. Most Medicare, BlueCross BlueShield, Aetna, Cigna, and UnitedHealthcare cover TMS therapy when clinically appropriate, typically requiring a diagnosis of treatment-resistant depression and documented failure of at least two antidepressant medications. Pre-authorisation from your insurer is usually required before starting treatment. Many U.S. clinics handle the prior authorisation process on your behalf.

What conditions does TMS treat?

TMS is primarily used to treat major depressive disorder (MDD) that has not responded adequately to medication. It is also FDA/NICE/Health Canada/TGA-cleared for OCD and smoking cessation, and clinical trials are ongoing for anxiety, PTSD, bipolar depression, and cognitive impairment. Your treating psychiatrist will determine whether TMS is appropriate for your specific diagnosis.

How much does TMS cost in United States?

Without insurance coverage, TMS costs approximately $300-$500 per session without insurance; insurance-covered courses typically have a copay of $30-$75 per session. With insurance or Medicare/NHS/provincial coverage, your out-of-pocket cost depends on your specific plan's copay, deductible, and coinsurance. Most patients with insurance coverage pay significantly less - often under $500 total for a full treatment course.

What TMS technologies are available?

The three main FDA/NICE/Health Canada/TGA-cleared TMS devices are NeuroStar (standard rTMS),BrainsWay Deep TMS (H-coil for broader brain coverage), and MagVenture (focal TMS with Theta Burst Protocol). Theta Burst Stimulation (TMS) is a newer protocol that reduces session time to 3-6 minutes per session while maintaining similar efficacy to standard protocols. Your psychiatrist will recommend the most appropriate technology based on your diagnosis and treatment history.

How do I know if I am a good candidate for TMS?

You may be a good candidate for TMS if you have been diagnosed with treatment-resistant depression (meaning you have tried two or more antidepressants without adequate relief), if you experience intolerable side effects from medication, or if you prefer a non-medication treatment approach. TMS is not recommended for patients with epilepsy, metal implants near the head, or active substance use disorders. Take our 2-minute eligibility quiz to see if you might qualify.